FDA Inspection 550550 — Biomat USA, Inc

Biomat USA, Inc — FEI 3003908050

The FDA completed an inspection of Biomat USA, Inc on December 4, 2008 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 4, 2008
Fiscal Year
2009
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Houston, TX (United States)

Citations

IDCFRDescription
15421 CFR 606.160(a)(1)Concurrent documentation
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs